1. Home
  2. DFLI vs THAR Comparison

DFLI vs THAR Comparison

Compare DFLI & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DFLI
  • THAR
  • Stock Information
  • Founded
  • DFLI 2020
  • THAR 2017
  • Country
  • DFLI United States
  • THAR United States
  • Employees
  • DFLI N/A
  • THAR N/A
  • Industry
  • DFLI Electronic Components
  • THAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • DFLI Technology
  • THAR Health Care
  • Exchange
  • DFLI Nasdaq
  • THAR Nasdaq
  • Market Cap
  • DFLI 14.5M
  • THAR 16.8M
  • IPO Year
  • DFLI N/A
  • THAR 2022
  • Fundamental
  • Price
  • DFLI $1.25
  • THAR $3.18
  • Analyst Decision
  • DFLI Strong Buy
  • THAR Strong Buy
  • Analyst Count
  • DFLI 1
  • THAR 1
  • Target Price
  • DFLI $1.50
  • THAR $17.00
  • AVG Volume (30 Days)
  • DFLI 67.0M
  • THAR 644.6K
  • Earning Date
  • DFLI 11-13-2025
  • THAR 11-06-2025
  • Dividend Yield
  • DFLI N/A
  • THAR N/A
  • EPS Growth
  • DFLI N/A
  • THAR N/A
  • EPS
  • DFLI N/A
  • THAR N/A
  • Revenue
  • DFLI $54,536,000.00
  • THAR N/A
  • Revenue This Year
  • DFLI $27.77
  • THAR N/A
  • Revenue Next Year
  • DFLI $42.02
  • THAR N/A
  • P/E Ratio
  • DFLI N/A
  • THAR N/A
  • Revenue Growth
  • DFLI 4.80
  • THAR N/A
  • 52 Week Low
  • DFLI $0.15
  • THAR $0.95
  • 52 Week High
  • DFLI $5.78
  • THAR $9.08
  • Technical
  • Relative Strength Index (RSI)
  • DFLI 65.50
  • THAR 49.85
  • Support Level
  • DFLI $1.30
  • THAR $2.88
  • Resistance Level
  • DFLI $1.71
  • THAR $3.17
  • Average True Range (ATR)
  • DFLI 0.21
  • THAR 0.31
  • MACD
  • DFLI 0.11
  • THAR -0.00
  • Stochastic Oscillator
  • DFLI 49.57
  • THAR 40.22

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

Share on Social Networks: